AAM
BMY icon

Azzad Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Azzad Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,953
Closed -$972K – 304
2023
Q4 		$972K Buy
18,953
+168
+0.9% +$8.82K 0.12% 216
2023
Q3 		$1.09M Sell
18,785
-44
-0.2% -$2.7K 0.15% 204
2023
Q2 		$1.2M Sell
18,829
-11,412
-38% -$765K 0.16% 204
2023
Q1 		$2.1M Buy
30,241
+477
+2% +$33.6K 0.3% 126
2022
Q4 		$2.14M Sell
29,764
-770
-3% -$58.1K 0.34% 116
2022
Q3 		$2.16M Sell
30,534
-5,315
-15% -$386K 0.22% 156
2022
Q2 		$2.75M Sell
35,849
-5,531
-13% -$421K 0.27% 129
2022
Q1 		$3.02M Buy
41,380
+2,341
+6% +$157K 0.44% 71
2021
Q4 		$2.43M Buy
39,039
+639
+2% +$37.5K 0.33% 114
2021
Q3 		$2.27M Buy
38,400
+8,170
+27% +$538K 0.34% 109
2021
Q2 		$2.02M Buy
30,230
+936
+3% +$61K 0.3% 141
2021
Q1 		$1.85M Buy
+29,294
New +$1.82M 0.31% 131
2019
Q3 		– Sell
-19,438
Closed -$882K – 357
2019
Q2 		$882K Sell
19,438
-181
-0.9% -$8.43K 0.24% 164
2019
Q1 		$936K Buy
19,619
+210
+1% +$10.5K 0.27% 147
2018
Q4 		$1.01M Buy
19,409
+3,480
+22% +$187K 0.34% 117
2018
Q3 		$989K Sell
15,929
-56
-0.4% -$3.32K 0.26% 148
2018
Q2 		$885K Buy
15,985
+330
+2% +$17.8K 0.25% 155
2018
Q1 		$990K Buy
15,655
+775
+5% +$49.9K 0.3% 130
2017
Q4 		$912K Buy
14,880
+859
+6% +$53.7K 0.29% 131
2017
Q3 		$894K Buy
14,021
+1,234
+10% +$72.1K 0.3% 123
2017
Q2 		$712K Buy
12,787
+1,435
+13% +$78.1K 0.26% 145
2017
Q1 		$617K Buy
11,352
+3,701
+48% +$203K 0.23% 168
2016
Q4 		$447K Buy
7,651
+381
+5% +$20.8K 0.18% 185
2016
Q3 		$392K Buy
7,270
+1,440
+25% +$92.5K 0.16% 200
2016
Q2 		$429K Buy
+5,830
New +$412K 0.18% 189

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Azzad Asset Management's BMY Position: Q1 2024 in Review

Azzad Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 18,953 shares — an estimated $972K sold.

Azzad Asset Management first reported a position in BMY in Q2 2016 and held it in 25 quarters. The position peaked at $3.02M in Q1 2022. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Azzad Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Azzad Asset Management sold 18,953 Bristol-Myers Squibb shares in Q1 2024, an estimated $972K.
  • Azzad Asset Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 25 quarters.
  • Azzad Asset Management's Bristol-Myers Squibb position peaked at $3.02M in Q1 2022.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Azzad Asset Management's 13F filing for Q1 2024, filed 19 Apr 2024.